Smarter Drugs: How Protein Crystallography Revolutionizes Drug Design
- SLAC National Accelerator Lab., Menlo Park, CA (United States)
According to Smith, protein crystallography allows scientists to design drugs in a much more efficient way than the standard methods traditionally used by large drug companies, which can cost close to a billion dollars and take 10 to 15 years. 'A lot of the work can be compressed down,' Smith said. Protein crystallography enables researchers to learn the structure of molecules involved in disease and health. Seeing the loops, folds and placement of atoms in anything from a virus to a healthy cell membrane gives important information about how these things work - and how to encourage, sidestep or stop their functions. Drug design can be much faster when the relationship between structure and function tells you what area of a molecule to target. Smith will use a timeline to illustrate the traditional methods of drug development and the new ways it can be done now. 'It is very exciting work. There have been some failures, but many successes too.' A new drug to combat the flu was developed in a year or so. Smith will tell us how. He will also highlight drugs developed to combat HIV, Tuberculosis, hypertension and Anthrax.
- Research Organization:
- SLAC National Accelerator Lab., Menlo Park, CA (United States)
- Sponsoring Organization:
- USDOE Office of Science (SC)
- DOE Contract Number:
- AC02-76SF00515
- OSTI ID:
- 1014029
- Resource Relation:
- Conference: SLAC Public Lecture Series, SLAC National Accelerator Laboratory, Menlo Park, California, presented on April 26, 2005
- Country of Publication:
- United States
- Language:
- English
Similar Records
Covalent inhibitors for eradication of drug-resistant HIV-1 reverse transcriptase: From design to protein crystallography
When Protein Crystallography Won't Show You the Membranes (446th Brookhaven Lecture)
Related Subjects
37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CHEMISTRY
60 APPLIED LIFE SCIENCES
AIDS VIRUS
ATOMS
CELL MEMBRANES
CRYSTALLOGRAPHY
DESIGN
DISEASES
DOLLARS
FERMILAB ACCELERATOR
HYPERTENSION
PROTEINS
STANFORD LINEAR ACCELERATOR CENTER
TUBERCULOSIS
SLAC
PROTEIN CRYSTALLOGRAPHY
DRUG DESIGN
DIFFRACTION PATTERN
DRUG RESISTANCE